In a research report issued today, Oppenheimer analyst Christopher Marai maintained an Outperform rating on MacroGenics (NASDAQ:MGNX) with a $48 price target, as the …
In a research note issued today to investors, Oppenheimer analyst Steven Lichtman maintained an Outperform rating on Medtronic (NYSE:MDT) with a $73 price target, …
In a research report published yesterday, Oppenheimer analyst Rick Schafer maintained a Perform rating on Semtech (NASDAQ:SMTC), following meetings with SMTC’s CFO, Emeka …
In a research report issued Thursday, Oppenheimer analyst Steve Manaker maintained a Perform rating on American Realty Capital Properties (NASDAQ:ARCP), as the company is …
In a research report released today, Oppenheimer analyst Brian Bittner reiterated an Outperform rating on Yum! Brands (NYSE:YUM) with an $80 price target.
In a research note issued today, Oppenheimer analyst Ittai Kidron maintained an Outperform rating on Cisco (NASDAQ:CSCO) with a $27 price target, following an investor event …
In a research report issued today to investors, Oppenheimer analyst Christopher Glynn downgraded shares of Eaton Corporation (NYSE:ETN) to Perform rating. No price target was …
In a research note published today, Oppenheimer analyst Akiva Felt maintained an Outperform rating on Zogenix (NASDAQ:ZGNX) with a $2.50 price target, as the …
In a research report today, Oppenheimer analyst Rohit Vanjani reiterated an Outperform rating on Igi Laboratories (NYSE:IG) with a $10 price target, following product acquisition …
In a research note published today, analyst Steven Lichtman of Oppenheimer assigned an Outperform rating on Integra Lifesciences (NASDAQ:IART) with a $57 price target. Lichtman commented: “During our …
